CME Group Inc (CME) Given Consensus Rating of “Buy” by Brokerages
CME Group Inc (NASDAQ:CME) has received a consensus recommendation of “Buy” from the eighteen brokerages that are covering the firm, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $193.87.
A number of analysts have weighed in on CME shares. UBS Group cut CME Group from a “buy” rating to a “neutral” rating and raised their price target for the company from $185.00 to $204.00 in a research note on Wednesday, November 28th. Jefferies Financial Group raised their price target on CME Group to $203.00 and gave the company a “buy” rating in a research note on Monday, October 8th. Zacks Investment Research upgraded CME Group from a “sell” rating to a “hold” rating in a research note on Tuesday, September 18th. Deutsche Bank restated a “buy” rating and issued a $192.00 price target (up from $185.00) on shares of CME Group in a research note on Thursday, October 11th. Finally, Bank of America restated a “buy” rating and issued a $200.00 price target on shares of CME Group in a research note on Monday, November 5th.
NASDAQ:CME traded up $0.72 during midday trading on Friday, reaching $180.57. The company had a trading volume of 57,947 shares, compared to its average volume of 1,905,944. The firm has a market cap of $60.69 billion, a PE ratio of 37.77, a price-to-earnings-growth ratio of 2.21 and a beta of 0.43. CME Group has a 12-month low of $149.38 and a 12-month high of $197.08. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.15.
The business also recently declared a dividend, which will be paid on Wednesday, January 16th. Investors of record on Friday, December 28th will be issued a dividend of $1.75 per share. The ex-dividend date of this dividend is Thursday, December 27th. CME Group’s dividend payout ratio is currently 58.70%.
In other CME Group news, CFO John W. Pietrowicz sold 17,960 shares of CME Group stock in a transaction that occurred on Wednesday, January 2nd. The stock was sold at an average price of $186.92, for a total value of $3,357,083.20. Following the sale, the chief financial officer now owns 44,780 shares of the company’s stock, valued at approximately $8,370,277.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman Terrence A. Duffy sold 10,000 shares of CME Group stock in a transaction that occurred on Friday, November 23rd. The shares were sold at an average price of $188.80, for a total value of $1,888,000.00. Following the completion of the sale, the chairman now directly owns 95,652 shares in the company, valued at approximately $18,059,097.60. The disclosure for this sale can be found here. In the last three months, insiders have sold 58,647 shares of company stock worth $11,107,550. Corporate insiders own 0.43% of the company’s stock.
Several large investors have recently made changes to their positions in the company. Moody National Bank Trust Division acquired a new position in shares of CME Group during the 4th quarter worth approximately $133,000. Prime Capital Investment Advisors LLC raised its holdings in CME Group by 282.5% in the 3rd quarter. Prime Capital Investment Advisors LLC now owns 765 shares of the financial services provider’s stock valued at $130,000 after acquiring an additional 565 shares during the last quarter. Honkamp Krueger Financial Services Inc. acquired a new position in CME Group in the 3rd quarter valued at $132,000. Bbva Compass Bancshares Inc. acquired a new position in CME Group in the 3rd quarter valued at $134,000. Finally, Buckley Wealth Management LLC acquired a new position in CME Group in the 3rd quarter valued at $201,000. 85.73% of the stock is currently owned by institutional investors and hedge funds.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Recommended Story: What is a blue-chip stock?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.